Methicillin-resistant Staphylococcus aureus infections.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23958361.
- Also identified by DOI 10.1016/j.pop.2013.06.002.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is an increasingly common multidrug-resistant clinical pathogen responsible for increasing health costs and for patient morbidity and mortality. Presented in this review, the definition, cell and molecular biology, epidemiology, prevention, diagnosis, and treatment of MRSA infections, including skin and soft tissue infections, bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system infections, are addressed. In the treatment of MRSA, this article highlights several common antibiotics that retain activity against different strains of MRSA.
Medical subject headings
- Anti-Bacterial Agents
- Methicillin-Resistant Staphylococcus aureus
- Primary Health Care
- Staphylococcal Infections